
CancerX Accelerator 2026 Cohort
CancerX Accelerator 2026 Cohort: who can apply, what you get and when it opens.
Some program details are not available yet. Check current requirements, deadlines, and terms before you apply. Official program page

CancerX Accelerator 2026 Cohort: who can apply, what you get and when it opens.
Some program details are not available yet. Check current requirements, deadlines, and terms before you apply. Official program page
The 2026 FAQ required a validated solution ready to scale, with a completed clinical pilot involving at least 50 patients living with cancer. It also specified at least 10 full-time employees or equivalent and a designated liaison to engage with the selection team. Applicants’ digital solutions had to relate directly to one of four theme areas, according to the FAQ.
The 2026 application window opened September 9, 2025, and the official guide set a final submission deadline of October 28, 2025, at 5:00 PM ET. The FAQ scheduled Pitch Days for advancing applicants on November 14 and 21, 2025, and said those who advanced would complete a supplemental application. Acceptance required strong interest from at least two champions. The 2026 application page linked to an application form, but its destination could not be read.
Who can apply, how people get in and whether it is open right now.
Programs pick people whose work they can already point to. Put yours where it can be found.
The program has not published how to apply. Terms and dates change. Check the official page before you act.
CancerX’s historical intake promotion stated that there was no application fee and that the accelerator took no equity. The evidence does not establish other participation costs or a stipend.
The 2026 FAQ required a validated, scale-ready solution with a completed clinical pilot involving at least 50 patients living with cancer, at least 10 full-time employees or equivalent, and a designated liaison. It also required the digital solution to relate directly to one of four theme areas.
No. The current official page places the 2026 cohort under alumni and advertises a separate 2027 intake; that later intake does not reopen the 2026 cohort.

Accelerator
Accelerating innovation in cancer care.
AcceleratorCancerX
CancerX Accelerator’s 2026 cohort was a participation cycle operated through a public-private partnership whose hosts CancerX identifies as Advocate Health and Moffitt Cancer Center. The application FAQ called for a validated product or sol
From public sources
The official 2026 application page links an Accelerator Application at Typeform, but the destination could not be read in this inspection.
Source: CancerX Accelerator Application 2026The current official page gives November 30, 2026 at 5 PM ET as the 2027 application deadline; this does not reopen the 2026 cohort.
Source: CancerX AcceleratorThe official accelerator page currently advertises applications for the 2027 cohort, separately from the 2026 alumni section.
Source: CancerX AcceleratorCancerX reports more than 55 mentor pairings for the 2026 cohort.
Source: CancerX 2026 impact report promotionCancerX reports 72 unique champion-startup engagements for the 2026 cohort.
Source: CancerX 2026 impact report promotionCancerX reports 33 potential deals generated by the 2026 cohort; these are not reported as closed deals.
Source: CancerX 2026 impact report promotionSuperscout Pro
Is this page right?Reviewed · How the research works